Clinical presentation of atopic dermatitis by filaggrin gene mutation status during the first 7 years of life in a prospective cohort study.

<h4>Background</h4>Filaggrin null mutations result in impaired skin barrier functions, increase the risk of early onset atopic dermatitis and lead to a more severe and chronic disease. We aimed to characterize the clinical presentation and course of atopic dermatitis associated with fila...

Full description

Bibliographic Details
Main Authors: Charlotte Giwercman Carson, Morten Arendt Rasmussen, Jacob P Thyssen, Torkil Menné, Hans Bisgaard
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23166590/pdf/?tool=EBI
id doaj-76c3b74cd2084b1a8ec1da67a10e0446
record_format Article
spelling doaj-76c3b74cd2084b1a8ec1da67a10e04462021-03-04T00:02:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01711e4867810.1371/journal.pone.0048678Clinical presentation of atopic dermatitis by filaggrin gene mutation status during the first 7 years of life in a prospective cohort study.Charlotte Giwercman CarsonMorten Arendt RasmussenJacob P ThyssenTorkil MennéHans Bisgaard<h4>Background</h4>Filaggrin null mutations result in impaired skin barrier functions, increase the risk of early onset atopic dermatitis and lead to a more severe and chronic disease. We aimed to characterize the clinical presentation and course of atopic dermatitis associated with filaggrin mutations within the first 7 years of life.<h4>Method</h4>The COPSAC cohort is a prospective, clinical birth cohort study of 411 children born to mothers with a history of asthma followed during their first 7 years of life with scheduled visits every 6 months, as well as visits for acute exacerbations of dermatitis. Atopic dermatitis was defined in accordance with international guidelines and described at every visit using 35 predefined localizations and 10 different characteristics.<h4>Results</h4>A total of 170 (43%) of 397 Caucasian children developed atopic dermatitis. The R501X and/or 2282del4 filaggrin null mutations were present in 26 (15%) of children with atopic dermatitis and were primarily associated with predilection to exposed skin areas (especially the cheeks and back of the hands) and an up-regulation of both acute and chronic dermatitis. Furthermore, we found the filaggrin mutations to be associated with a higher number of unscheduled visits (3.6 vs. 2.7; p=0.04) and more severe (moderate-severe SCORAD 44% vs. 31%; p=0.14), and widespread dermatitis (10% vs. 6% of the body area, p<0.001) with an earlier age at onset (246 vs. 473 days, p<0.0001) compared to wild-type.<h4>Conclusion</h4>In children, filaggrin mutations seem to define a specific endotype of atopic dermatitis primarily characterized by predilection to exposed areas of the body, in particular hands and cheeks, and an up-regulation in both acute and chronic morphological markers. Secondary, this endotype is characterized by an early onset of dermatitis and a more severe course, with more generalized dermatitis resulting in more frequent medical consultations.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23166590/pdf/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Charlotte Giwercman Carson
Morten Arendt Rasmussen
Jacob P Thyssen
Torkil Menné
Hans Bisgaard
spellingShingle Charlotte Giwercman Carson
Morten Arendt Rasmussen
Jacob P Thyssen
Torkil Menné
Hans Bisgaard
Clinical presentation of atopic dermatitis by filaggrin gene mutation status during the first 7 years of life in a prospective cohort study.
PLoS ONE
author_facet Charlotte Giwercman Carson
Morten Arendt Rasmussen
Jacob P Thyssen
Torkil Menné
Hans Bisgaard
author_sort Charlotte Giwercman Carson
title Clinical presentation of atopic dermatitis by filaggrin gene mutation status during the first 7 years of life in a prospective cohort study.
title_short Clinical presentation of atopic dermatitis by filaggrin gene mutation status during the first 7 years of life in a prospective cohort study.
title_full Clinical presentation of atopic dermatitis by filaggrin gene mutation status during the first 7 years of life in a prospective cohort study.
title_fullStr Clinical presentation of atopic dermatitis by filaggrin gene mutation status during the first 7 years of life in a prospective cohort study.
title_full_unstemmed Clinical presentation of atopic dermatitis by filaggrin gene mutation status during the first 7 years of life in a prospective cohort study.
title_sort clinical presentation of atopic dermatitis by filaggrin gene mutation status during the first 7 years of life in a prospective cohort study.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description <h4>Background</h4>Filaggrin null mutations result in impaired skin barrier functions, increase the risk of early onset atopic dermatitis and lead to a more severe and chronic disease. We aimed to characterize the clinical presentation and course of atopic dermatitis associated with filaggrin mutations within the first 7 years of life.<h4>Method</h4>The COPSAC cohort is a prospective, clinical birth cohort study of 411 children born to mothers with a history of asthma followed during their first 7 years of life with scheduled visits every 6 months, as well as visits for acute exacerbations of dermatitis. Atopic dermatitis was defined in accordance with international guidelines and described at every visit using 35 predefined localizations and 10 different characteristics.<h4>Results</h4>A total of 170 (43%) of 397 Caucasian children developed atopic dermatitis. The R501X and/or 2282del4 filaggrin null mutations were present in 26 (15%) of children with atopic dermatitis and were primarily associated with predilection to exposed skin areas (especially the cheeks and back of the hands) and an up-regulation of both acute and chronic dermatitis. Furthermore, we found the filaggrin mutations to be associated with a higher number of unscheduled visits (3.6 vs. 2.7; p=0.04) and more severe (moderate-severe SCORAD 44% vs. 31%; p=0.14), and widespread dermatitis (10% vs. 6% of the body area, p<0.001) with an earlier age at onset (246 vs. 473 days, p<0.0001) compared to wild-type.<h4>Conclusion</h4>In children, filaggrin mutations seem to define a specific endotype of atopic dermatitis primarily characterized by predilection to exposed areas of the body, in particular hands and cheeks, and an up-regulation in both acute and chronic morphological markers. Secondary, this endotype is characterized by an early onset of dermatitis and a more severe course, with more generalized dermatitis resulting in more frequent medical consultations.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23166590/pdf/?tool=EBI
work_keys_str_mv AT charlottegiwercmancarson clinicalpresentationofatopicdermatitisbyfilaggringenemutationstatusduringthefirst7yearsoflifeinaprospectivecohortstudy
AT mortenarendtrasmussen clinicalpresentationofatopicdermatitisbyfilaggringenemutationstatusduringthefirst7yearsoflifeinaprospectivecohortstudy
AT jacobpthyssen clinicalpresentationofatopicdermatitisbyfilaggringenemutationstatusduringthefirst7yearsoflifeinaprospectivecohortstudy
AT torkilmenne clinicalpresentationofatopicdermatitisbyfilaggringenemutationstatusduringthefirst7yearsoflifeinaprospectivecohortstudy
AT hansbisgaard clinicalpresentationofatopicdermatitisbyfilaggringenemutationstatusduringthefirst7yearsoflifeinaprospectivecohortstudy
_version_ 1714810808328781824